Belatacept For Immunosuppression Optimization In Heart Transplantation: A Case Of Improved Adherence And Donor-derived Cell-Free DNA Reduction [Poster no. 179]
Clarke Morihara1, Miles Miki2, Alexander Cotter3, Thanaboon Yinadsawaphan2, Bradon hong2, Bert Matsuo4, Kevin Benavente5, Jesus Pino Moreno4, Abdulelah Nuqali6. 1University of Hawaii Internal Medicine Residency Program, Mililani, HI; 2University of Hawaii Internal Medicine Residency Program, Honolulu, HI; 3University of Hawaii Internal Medicine Residency Program; 4The Queen's Medical Center, Honolulu, HI; 5University of Hawaii Cardiovascular Disease Fellowship Program, Honolulu, HI; 6The Queen's Medical Center, Kansas City, MO
Clarke MoriharaMDHawaii Residency Program;University of Hawaii Internal Medicine Residency ProgramClarke Morihara1, Miles Miki2, Alexander Cotter3, Thanaboon Yinadsawaphan2, Bradon hong2, Bert Matsuo4, Kevin Benavente5, Jesus Pino Moreno4, Abdulelah Nuqali6. 1University of Hawaii Internal Medicine Residency Program, Mililani, HI; 2University of Hawaii Internal Medicine Residency Program, Honolulu, HI; 3University of Hawaii Internal Medicine Residency Program; 4The Queen's Medical Center, Honolulu, HI; 5University of Hawaii Cardiovascular Disease Fellowship Program, Honolulu, HI; 6The Queen's Medical Center, Kansas City, MOGeneric 'disconnected' MessageCESession Type